Brawn Biotech appoints GDSM and Co. as statutory auditors till FY31

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Appointed M/s. GDSM and Co. as statutory auditors effective September 29, 2026
  • Auditor tenure extends through FY31 (Financial Year 2030-31)
  • Reappointed Brij Raj Gupta as Director following retirement by rotation
  • Gupta holds 500,774 equity shares as on March 31, 2026
powered bylight_fuzz_icon
52223403

*this image is generated using AI for illustrative purposes only.

Brawn Biotech Ltd has appointed M/s. GDSM and Co. Chartered Accountants as its statutory auditors with effect from September 29, 2026. The appointment follows shareholder approval at the Annual General Meeting and covers a tenure extending through FY31.

The company disclosed the development to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resolution was part of a set of approvals outlined in the notice dated August 13, 2026.

Auditor details and tenure

M/s. GDSM and Co., bearing Firm Registration No. 034194N, will serve as the statutory auditor until the conclusion of the financial year 2030-31. The firm offers a comprehensive range of services including audits under the Companies Act, income tax, GST audit, internal audit, and consultancy in taxation and company law matters.

The disclosure confirms that the appointment is not related to any resignation or removal of the previous auditor but is a fresh appointment approved by members.

Director reappointment

Alongside the auditor appointment, shareholders approved the reappointment of Brij Raj Gupta as Director. Gupta, who retired by rotation at the AGM, continues in his role liable to retire by rotation.

Detail Particulars
Name Brij Raj Gupta
DIN 00974969
Age 74 years
Date of Birth April 15, 1952
Initial Appointment Date November 7, 1985
Equity Shares Held (as on March 31, 2026) 500,774
Skills & Experience Expertise in pharmaceutical business; associated with the company for a long period

The filing notes that Gupta holds 500,774 equity shares in the company as on March 31, 2026. His initial appointment dates back to November 7, 1985, indicating a long-standing association with the pharmaceutical entity.

Historical Stock Returns for Brawn Biotech

1 Day5 Days1 Month6 Months1 Year5 Years
+4.37%+14.42%+2.71%0.0%+16.81%+23.31%

How might the new five-year audit tenure with GDSM and Co. influence Brawn Biotech's long-term financial reporting consistency and investor confidence?

Given Brij Raj Gupta's age of 74 and tenure since 1985, what succession planning strategies is the board implementing to ensure leadership continuity?

Will the appointment of GDSM and Co., known for comprehensive tax and compliance services, lead to changes in Brawn Biotech's operational cost structure or tax efficiency?

Brawn Biotech passes all resolutions at 41st AGM; promoters back re-appointment

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • All four ordinary resolutions passed at Brawn Biotech's 41st AGM held on September 29, 2026
  • Promoter group voted 100% in favour across all items, casting 10,00,574 votes each
  • Public shareholders supported financial statement adoption with 97.84% votes in favour
  • Managerial remuneration approval saw lower public support at 94.58% compared to other items
powered bylight_fuzz_icon
52212614

*this image is generated using AI for illustrative purposes only.

Brawn Biotech Ltd concluded its 41st Annual General Meeting on September 29, 2026, with all proposed resolutions passing through the requisite majority. The meeting was conducted entirely through Video Conferencing and Other Audio Visual Means (VC/OAVM).

The session commenced at 11:00 am and concluded ten minutes later at 11:10 am. Brij Raj Gupta served as the Chairman of the meeting. The company confirmed that the results were validated by a scrutinizer's report dated September 29, 2026.

Meeting details and compliance

The Annual General Meeting was convened in accordance with the notice issued on August 13, 2026. As per standard corporate governance practices, the detailed proceedings and voting results will be uploaded to the company's official website and submitted to the stock exchanges for public record.

Priyanka Sharma, Company Secretary and Compliance Officer, signed off on the communication to the Bombay Stock Exchange (BSE). The filing confirms that no physical venue was utilized for this annual gathering, reflecting continued adoption of digital shareholder engagement methods.

Resolutions passed at the meeting

The meeting addressed four ordinary resolutions covering financial statements, board composition, statutory auditors, and managerial remuneration. Members present through VC and other audio-visual means totaled 44. The scrutinizer for the voting process was Mr. Viney, Company Secretary in Practice.

Resolution Particulars Type
1 To receive, consider and adopt the Audited Financial Statement for FY26, including Balance Sheet, P&L, Cash Flow, Board Report, and Auditors' Report Ordinary
2 To appoint a director in place of Mr. Brij Raj Gupta (DIN: 00974969), who retires by rotation and offers himself for re-appointment Ordinary
3 Appointment of M/s. G D S M and Co. Chartered Accountants (Firm Registration No. 034194N) as Statutory Auditors Ordinary
4 To consider and approve managerial remuneration of Mr. Amit Kumar (Manager-KMP) as per Companies Act, 2013 Ordinary

The company noted that there were no qualifications in the Audit Report or Secretarial Audit Report, so these were not read aloud during the session. Nine shareholders registered as speakers, and questions raised were addressed by the Company Secretary.

Voting participation breakdown

The scrutinizer report disclosed specific participation metrics. A total of 89 members cast their votes through remote e-voting, while 0 members voted via e-voting during the live AGM session. The cut-off date for determining voting entitlements was September 22, 2026.

In terms of shareholder presence, 44 shareholders attended virtually, comprising 3 from the promoter group and 41 from the public category. The total number of shareholders as on the cut-off date stood at 3,271.

Detailed voting outcomes

For the first three resolutions, including the adoption of financial statements and auditor appointment, the voting pattern remained consistent. Promoters and promoter group voted 100% in favour, casting 10,00,574 votes. Public shareholders cast 924 votes, with 904 in favour and 20 against, resulting in a 97.84% support rate from the public category.

Resolution 4, concerning the managerial remuneration of Mr. Amit Kumar, saw slightly different public sentiment. While promoters again voted 100% in favour with 10,00,574 votes, public shareholders cast 924 votes, of which 874 were in favour and 50 against. This resulted in a 94.58% support rate from public shareholders for this specific item.

All four resolutions passed with the requisite majority, confirming the board's proposed actions for FY26.

Historical Stock Returns for Brawn Biotech

1 Day5 Days1 Month6 Months1 Year5 Years
+4.37%+14.42%+2.71%0.0%+16.81%+23.31%

How will the newly appointed statutory auditors, M/s. G D S M and Co., influence Brawn Biotech's financial reporting strategy and audit rigor for FY27?

What specific operational or strategic factors drove the audited financial performance for FY26 that was adopted during the AGM?

Will the slight dip in public shareholder support for managerial remuneration signal broader governance concerns that could impact future executive compensation approvals?

More News on Brawn Biotech

1 Year Returns:+16.81%